These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1981577)

  • 1. The parenteral controlled release of liposome encapsulated chloroquine in mice.
    Titulaer HA; Eling WM; Crommelin DJ; Peeters PA; Zuidema J
    J Pharm Pharmacol; 1990 Aug; 42(8):529-32. PubMed ID: 1981577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue reaction after intramuscular injection of liposomes in mice.
    Kadir F; Eling WM; Abrahams D; Zuidema J; Crommelin DJ
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):374-82. PubMed ID: 1446954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divided dose intramuscular regimen and single dose subcutaneous regimen for chloroquine: plasma concentrations and toxicity in patients with malaria.
    Phillips RE; Warrell DA; Edwards G; Galagedera Y; Theakston RD; Abeysekera DT; Dissanayaka P
    Br Med J (Clin Res Ed); 1986 Jul; 293(6538):13-6. PubMed ID: 3524744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria.
    Peeters PA; de Leest K; Eling WM; Crommelin DJ
    Pharm Res; 1989 Sep; 6(9):787-93. PubMed ID: 2682591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain.
    Smith LJ; Krugner-Higby L; Clark M; Wendland A; Heath TD
    Comp Med; 2003 Jun; 53(3):280-7. PubMed ID: 12868573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of subcutaneously administered chloroquine in the rat.
    Grundmann M; Mikulíková I; Vrublovský P
    Arzneimittelforschung; 1971 Apr; 21(4):573-4. PubMed ID: 5108164
    [No Abstract]   [Full Text] [Related]  

  • 7. Parenteral chloroquine for treating falciparum malaria.
    White NJ; Watt G; Bergqvist Y; Njelesani EK
    J Infect Dis; 1987 Feb; 155(2):192-201. PubMed ID: 3543146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.
    Angst MS; Drover DR
    Clin Pharmacokinet; 2006; 45(12):1153-76. PubMed ID: 17112293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of negatively and positively charged liposomes containing entrapped polyinosinic-polycytidylic acid for interferon induction in mice.
    Magee WE; Talcott ML; Straub SX; Vriend CY
    Biochim Biophys Acta; 1976 Dec; 451(2):610-8. PubMed ID: 999873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration.
    Anderson PM; Katsanis E; Sencer SF; Hasz D; Ochoa AC; Bostrom B
    J Immunother (1991); 1992 Jul; 12(1):19-31. PubMed ID: 1637781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo ESR studies on subcutaneously injected multilamellar liposomes in living mice.
    Moll KP; Stösser R; Herrmann W; Borchert HH; Utsumi H
    Pharm Res; 2004 Nov; 21(11):2017-24. PubMed ID: 15587923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of route of administration on the pharmaco-kinetics of chloroquine and desethylchloroquine.
    Salako LA; Aderounmu AF; Walker O
    Bull World Health Organ; 1987; 65(1):47-50. PubMed ID: 3495365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of liposome-encapsulated human interferon-gamma after intravenous and intramuscular injection in mice.
    Rutenfranz I; Bauer A; Kirchner H
    J Interferon Res; 1990 Jun; 10(3):337-41. PubMed ID: 2117038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment.
    Düzgüneş N; Ashtekar DR; Flasher DL; Ghori N; Debs RJ; Friend DS; Gangadharam PR
    J Infect Dis; 1991 Jul; 164(1):143-51. PubMed ID: 2056201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration.
    Fielding RM; Moon-McDermott L; Lewis RO
    J Drug Target; 1999; 6(6):415-26. PubMed ID: 10937287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection.
    Allen TM; Hansen CB; Guo LS
    Biochim Biophys Acta; 1993 Jul; 1150(1):9-16. PubMed ID: 8334142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.
    Cabanes A; Reig F; Antón JM; Arboix M
    Am J Vet Res; 1995 Nov; 56(11):1498-501. PubMed ID: 8585663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massage-induced release of subcutaneously injected liposome-encapsulated drugs to the blood.
    Trubetskoy VS; Whiteman KR; Torchilin VP; Wolf GL
    J Control Release; 1998 Jan; 50(1-3):13-9. PubMed ID: 9685868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulation persistence and biodistribution of lyophilized liposome-encapsulated hemoglobin: an oxygen-carrying resuscitative fluid.
    Rudolph AS; Cliff RO; Klipper R; Goins B; Phillips WT
    Crit Care Med; 1994 Jan; 22(1):142-50. PubMed ID: 8124957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivesicular liposomes containing bleomycin for subcutaneous administration.
    Roy R; Kim S
    Cancer Chemother Pharmacol; 1991; 28(2):105-8. PubMed ID: 1711933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.